In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug company based in Shanghai. One month later, at a hospital in the city, a New Zealander with advanced cancer of the stomach and small intestine became the first international patient to receive the breakthrough treatment.
Chimeric antigen receptor T-cell therapy, to give it its full name, is a cutting-edge treatment that, until then, had only been approved to treat blood...
China’s cancer breakthrough on CAR-T cell therapy shows progress
Global - Asia
Archived
•
September 22, 2026
•
Source: South China Morning Post | https://www.scmp.com/rss/91/feed - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



